If prolactin excess is not complicated by irreversible changes in the vascular system and/or glucose homeostasis, calciferol supplementation-induced normalization of vitamin D status may reduce the likelihood of developing atherosclerosis, diabetes, and metabolic syndrome to the level observed in the general population of young women. The gene discussed is PRL; the disease is atherosclerosis.